QR-Code

Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)

Objective To evaluate the efficacy of ginkgo biloba, acetazolamide, and their combination as prophylaxis against acute mountain sickness. Design Prospective, double blind, randomised, placebo controlled trial. Setting Approach to Mount Everest base camp in the Nepal Himalayas at 4280 m or 4358 m and...

Ausführliche Beschreibung

Gespeichert in:
Bibliografische Detailangaben
Veröffentlicht in:BMJ
Hauptverfasser: Gertsch, Jeffrey H, Basnyat, Buddha, Johnson, E William, Onopa, Janet, Holck, Peter S
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2004
Schlagworte:
Online-Zugang:https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC383373/
https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15070635/
https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.38043.501690.7C
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!